Lázničková, P., Tidu, F., Hrdý, J., Boráková, K., Hortová Kohoutková, M., & Frič, J. (2025). High-Risk neuroblastoma therapeutics Topotecan and 13-cis-Retinoic acid modulate autophagy and induce DNA damage response in hematopoietic stem cells and monocytes. Scientific Reports, 15(1), 1. https://doi.org/10.1038/s41598-025-19454-0
Chicago Style (17th ed.) CitationLázničková, Petra, Federico Tidu, Jiří Hrdý, Kristýna Boráková, Marcela Hortová Kohoutková, and Jan Frič. "High-Risk Neuroblastoma Therapeutics Topotecan and 13-cis-Retinoic Acid Modulate Autophagy and Induce DNA Damage Response in Hematopoietic Stem Cells and Monocytes." Scientific Reports 15, no. 1 (2025): 1. https://doi.org/10.1038/s41598-025-19454-0.
MLA (9th ed.) CitationLázničková, Petra, et al. "High-Risk Neuroblastoma Therapeutics Topotecan and 13-cis-Retinoic Acid Modulate Autophagy and Induce DNA Damage Response in Hematopoietic Stem Cells and Monocytes." Scientific Reports, vol. 15, no. 1, 2025, p. 1, https://doi.org/10.1038/s41598-025-19454-0.